What are Evogene Ltd's key financial statements?

According to the latest financial statement (Form-10K), Evogene Ltd has a total asset of $0, Net loss of $0

What are the key financial ratios for EVGN?

Evogene Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Evogene Ltd's revenue broken down by segment or geography?

Evogene Ltd largest revenue segment is Industrial Applications, at a revenue of 2,168,000 in the most earnings release.For geography, Africa is the primary market for Evogene Ltd, at a revenue of 2,042,090.

Is Evogene Ltd profitable?

no, according to the latest financial statements, Evogene Ltd has a net loss of $0

Does Evogene Ltd have any liabilities?

no, Evogene Ltd has liability of 0

How many outstanding shares for Evogene Ltd?

Evogene Ltd has a total outstanding shares of 0

EVGN Financials: Evogene Ltd AI Analysis



Financials

EVGN Financial

Evogene Ltd

$0.43

1.86%

$0

As of today:Jul 06, 17:26:11 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.4297

Open

$0.43

Day's Range

$0.4117 - $0.4408

52 week range

$0.4377 - $2.03

Volume

109.7K

Avg.Volume

656.9K

Dividend yield

EPS (TTM)

-1.38

Market Cap

$3.8M

What is EVGN?

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 142 full-time employees. The company went IPO on 2007-06-11. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	1	0	0	0	0	2
Revenue Growth (YoY)	--	-100%	-100%	--	--	--
Cost of Revenue	0	0	0	0	0	1
Gross Profit	1	0	0	0	0	0
Selling, General & Admin	5	1	1	1	1	1
Research & Development	6	1	1	1	1	--
Operating Expenses	14	3	3	2	2	5
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-16	-5	-5	-2	-2	-2
Income Tax Expense	0	0	0	0	0	0
Net Income	-11	-5	-5	3	-4	-2
Net Income Growth	--	150%	--	--	--	--
Shares Outstanding (Diluted)	9.73	9.73	8.73	8.71	7.22	6.8
Shares Change (YoY)	--	43%	28%	--	--	--
EPS (Diluted)	-1.2	-0.6	-0.6	0.44	-0.61	-0.38
EPS Growth	--	59%	-1,111%	--	--	--
Free Cash Flow	-11	-2	-2	-3	-2	-5
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	100%	0%	0%	0%	0%	0%
Operating Margin	-1,200%	0%	0%	0%	0%	-200%
Profit Margin	-1,100%	0%	0%	0%	0%	-100%
Free Cash Flow Margin	-1,100%	0%	0%	0%	0%	-250%
EBITDA	-11	-3	-2	-2	-1	-4
EBITDA Margin	-1,100%	0%	0%	0%	0%	-200%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-12	-3	-2	-2	-1	-4
EBIT Margin	-1,200%	0%	0%	0%	0%	-200%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Evogene Ltd (EVGN) Financial

EVGN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EVGN?

Evogene Ltd (EVGN) Financial

EVGN Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EVGN?

EVGN Income

Follow-Up Questions

What are Evogene Ltd's key financial statements?

What are the key financial ratios for EVGN?

How is Evogene Ltd's revenue broken down by segment or geography?

Is Evogene Ltd profitable?

Does Evogene Ltd have any liabilities?

How many outstanding shares for Evogene Ltd?